Administrative Supplements for NIMH Grants to Expand Suicide Research Suicide is among the top leading causes of death in the US; individuals with schizophrenia (Sz) have a lifetime risk of more than tenfold that of the general population. Suicidal ideation and behavior (SIB) are prevalent also in clinical risk states for schizophrenia, in teens and young adults at increased clinical high risk (CHR) for Sz and related psychotic disorders, based on attenuated psychotic symptoms (APS). In CHR cohorts, lifetime prevalence is ~77% for suicidal ideation and ~20% for suicidal behavior and attempts. Base rates for suicide by death after ascertainment is ~1% within a few years. Despite the clear public health problem of SIB in CHR teens and young adults, there is a clear gap in our understanding of their associated mechanisms and neural substrates, and their demographic, symptom and clinical correlates. It is important to gain a better understanding of SIB in CHR individuals in order to extend prevention efforts for CHR individuals beyond prevention of psychosis and poor functional outcome to include suicide prevention as well. This proposal is an administrative supplement submitted in response to NOT-MH-19-026 Administrative Supplements for NIMH Grants to Expand Suicide Research, for the parent R01 of ?Thought disorder and social cognition in clinical risk states for schizophrenia? (end 2021). It capitalizes on the parent R01's prospective cohort that includes data across multiple levels of analysis, including behavior (language, social cognition, symptoms) and circuits (brain structure and function), as well as data on SIB collected for purposes of safety, using the PhenX toolkit measure of the Columbia Suicide Severity Rating Scale (C-SSRS). Therefore, this supplement does not entail the addition of any new measures. It is expected there will be data on 90 CHR, 25 Sz, and 25 healthy individuals by mid-2020 amenable for analysis (preliminary data now includes 30 CHR). This supplement adds a new specific aim relevant to suicide risk, namely to identify linguistic/cognitive biomarkers, symptom/demographic correlates and neural substrates of C-SSRS SIB in CHR individuals using advanced analytic methods, including natural language processing, machine learning, penalized regression, and sparse modeling. The work proposed is within the scope of the parent R01 as it entails the application of similar advanced analytic methods to the same dataset, to understand mechanisms of key clinical features in a young at-risk cohort (parent R01: psychosis risk: supplement: suicide risk). It is hypothesized that SIB will be associated in CHR individuals with greater use of words with negative emotional content and greater self-focus in language (use of personal pronouns), social cognitive deficits, depression, motivational deficits, gray matter reduction and abnormal resting connectivity.

Public Health Relevance

Suicidal ideation and behavior (SIB) is prevalent in schizophrenia and related psychotic disorders, including during putative prodromal stages, in teens and young adults at clinical high risk (CHR) for psychosis; however, little is known about the mechanisms and neural substrates that underlie SIB in at-risk youths. This proposal for an administrative supplement capitalizes on a large prospective CHR cohort study that has data available across behavioral (language, social cognition, symptoms) and circuit-based (brain structure and function) levels, as well as safety data on SIB from a measure in the PhenX toolkit. It employs advanced analytic methods and automated language analysis to gain a better understanding of SIB in psychosis risk states, key for development of suicide prevention efforts in this risk group of young people.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
3R01MH107558-05S1
Application #
9941435
Study Section
Program Officer
Wijtenburg, Andrea
Project Start
2017-12-19
Project End
2020-04-30
Budget Start
2020-01-06
Budget End
2020-04-30
Support Year
5
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Icahn School of Medicine at Mount Sinai
Department
Psychiatry
Type
Schools of Medicine
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
Corcoran, Cheryl M; Carrillo, Facundo; Fernández-Slezak, Diego et al. (2018) Prediction of psychosis across protocols and risk cohorts using automated language analysis. World Psychiatry 17:67-75
Corcoran, Cheryl M; Stoops, Anastasia; Lee, Migyung et al. (2018) Developmental trajectory of mismatch negativity and visual event-related potentials in healthy controls: Implications for neurodevelopmental vs. neurodegenerative models of schizophrenia. Schizophr Res 191:101-108
Corcoran, Cheryl M; Cecchi, Guillermo A (2018) Computational Approaches to Behavior Analysis in Psychiatry. Neuropsychopharmacology 43:225-226
Lieberman, J A; Girgis, R R; Brucato, G et al. (2018) Hippocampal dysfunction in the pathophysiology of schizophrenia: a selective review and hypothesis for early detection and intervention. Mol Psychiatry 23:1764-1772
Crump, Francesca M; Arndt, Leigh; Grivel, Margaux et al. (2018) Attenuated first-rank symptoms and conversion to psychosis in a clinical high-risk cohort. Early Interv Psychiatry 12:1213-1216
Masucci, Michael D; Lister, Amanda; Corcoran, Cheryl M et al. (2018) Motor Dysfunction as a Risk Factor for Conversion to Psychosis Independent of Medication Use in a Psychosis-Risk Cohort. J Nerv Ment Dis 206:356-361
Corcoran, Cheryl (2017) Taking care of the carers: support for families of persons with early psychosis. World Psychiatry 16:267-268
Poe, Sarah-Lucy; Brucato, Gary; Bruno, Nicolina et al. (2017) Sleep disturbances in individuals at clinical high risk for psychosis. Psychiatry Res 249:240-243
Redman, Samantha L; Corcoran, Cheryl M; Kimhy, David et al. (2017) Effects of early trauma on psychosis development in clinical high-risk individuals and stability of trauma assessment across studies: a review. Arch Psychol (Chic) 1:
Vadhan, Nehal P; Corcoran, Cheryl M; Bedi, Gill et al. (2017) Acute effects of smoked marijuana in marijuana smokers at clinical high-risk for psychosis: A preliminary study. Psychiatry Res 257:372-374

Showing the most recent 10 out of 18 publications